Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

BioRestorative Therapies, Inc. (BRTX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
   S-1/A10-K10-K10-K10-K10-K10-K10-K
Cash flows from operating activities:          
    Net Loss  -11.3-14.6-12.5-9.4-8.6-7.9-5.6-5.8
    Adjustments to reconcile net loss to net cash used in operating activities:          
        Depreciation and amortization  0.10.20.20.30.30.20.10.1
        Stock-based compensation  0.71.72.43.62.52.01.40.8
        Changes in operating assets and liabilities:          
            Accounts receivable  0.00.00.00.00.1-0.1  
            Prepaid assets and other current assets  -0.10.00.00.00.00.00.00.0
            Accounts payable  0.10.1-0.50.2-0.11.4-0.20.5
            Accrued expenses and other current liabilities  0.50.40.50.60.21.0 1.0
                Net cash used in operating activities  -2.0-6.9-5.1-3.9-5.0-3.1-3.2-2.7
   
Cash flows from investing activities:          
    Purchases of equipment   0.00.00.0-0.2-0.4-0.20.0
        Net cash provided by (used in) investing activities  2.50.00.00.0-0.2-0.5-0.20.0
   
Cash flows from financing activities:          
    Net proceeds from issuance of common stock in at-the-market offering  0.0       
        Net cash provided by financing activities  5.06.84.84.35.13.73.32.9
   
Supplemental cash flow information:          
    Cash paid for:          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy